Correlation Between PYC Therapeutics and Cochlear

Can any of the company-specific risk be diversified away by investing in both PYC Therapeutics and Cochlear at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PYC Therapeutics and Cochlear into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PYC Therapeutics and Cochlear, you can compare the effects of market volatilities on PYC Therapeutics and Cochlear and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PYC Therapeutics with a short position of Cochlear. Check out your portfolio center. Please also check ongoing floating volatility patterns of PYC Therapeutics and Cochlear.

Diversification Opportunities for PYC Therapeutics and Cochlear

-0.04

Correlation Coefficient

PYC Therapeutics  Cochlear

Good diversification

The 3 months correlation between PYC and Cochlear is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding PYC Therapeutics and Cochlear in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cochlear and PYC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PYC Therapeutics are associated (or correlated) with Cochlear. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cochlear has no effect on the direction of PYC Therapeutics i.e., PYC Therapeutics and Cochlear go up and down completely randomly.

Pair Corralation between PYC Therapeutics and Cochlear

Assuming the 90 days trading horizon PYC Therapeutics is expected to generate 3.44 times more return on investment than Cochlear. However, PYC Therapeutics is 3.44 times more volatile than Cochlear. It trades about 0.07 of its potential returns per unit of risk. Cochlear is currently generating about -0.03 per unit of risk. If you would invest  97.00  in PYC Therapeutics on September 27, 2024 and sell it today you would earn a total of  43.00  from holding PYC Therapeutics or generate 44.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

PYC Therapeutics  vs.  Cochlear

PYC Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cochlear

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cochlear are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical indicators, Cochlear is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with PYC Therapeutics and Cochlear

The main advantage of trading using opposite PYC Therapeutics and Cochlear positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PYC Therapeutics position performs unexpectedly, Cochlear can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cochlear will offset losses from the drop in Cochlear's long position.

The idea behind PYC Therapeutics and Cochlear pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.